$CHRS
Coherus BioSciences Inc

2017 Q2 Form 10-Q Financial Statement

#000156459017016017 Filed on August 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $1.395M $14.07M
YoY Change -90.08% 104.89%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $23.50M $11.30M
YoY Change 107.96% 28.41%
% of Gross Profit
Research & Development $34.50M $65.54M
YoY Change -47.36% 15.1%
% of Gross Profit
Depreciation & Amortization $800.0K $700.0K
YoY Change 14.29% 75.0%
% of Gross Profit
Operating Expenses $58.03M $76.80M
YoY Change -24.44% 16.79%
Operating Profit
YoY Change
Interest Expense -$2.400M $2.354M
YoY Change -201.95%
% of Operating Profit
Other Income/Expense, Net $3.600M -$5.060M
YoY Change -171.15% 3540.29%
Pretax Income -$55.40M -$70.20M
YoY Change -21.08% 18.98%
Income Tax
% Of Pretax Income
Net Earnings -$55.34M -$69.97M
YoY Change -20.91% 18.97%
Net Earnings / Revenue -3966.74% -497.35%
Basic Earnings Per Share -$1.72
Diluted Earnings Per Share -$1.078M -$1.72
COMMON SHARES
Basic Shares Outstanding 40.70M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.3M $220.9M
YoY Change -46.45% 7.18%
Cash & Equivalents $73.35M $220.9M
Short-Term Investments $45.00M
Other Short-Term Assets $35.00M $431.0K
YoY Change 8020.65% -87.11%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $153.3M $236.8M
YoY Change -35.27% -1.15%
LONG-TERM ASSETS
Property, Plant & Equipment $14.50M $9.904M
YoY Change 46.41% 56.19%
Goodwill $943.0K
YoY Change 0.0%
Intangibles $2.620M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $800.0K $15.00K
YoY Change 5233.33% -70.0%
Total Long-Term Assets $19.00M $14.27M
YoY Change 33.17% 43.33%
TOTAL ASSETS
Total Short-Term Assets $153.3M $236.8M
Total Long-Term Assets $19.00M $14.27M
Total Assets $172.3M $251.1M
YoY Change -31.38% 0.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.80M $17.43M
YoY Change -9.37% 23.72%
Accrued Expenses $17.10M $19.18M
YoY Change -10.86% -0.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.95M $108.3M
YoY Change -66.81% 54.83%
LONG-TERM LIABILITIES
Long-Term Debt $100.9M $99.60M
YoY Change 1.31%
Other Long-Term Liabilities $2.111M $105.1M
YoY Change -97.99% 32846.71%
Total Long-Term Liabilities $2.111M $204.7M
YoY Change -98.97% 64069.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.95M $108.3M
Total Long-Term Liabilities $2.111M $204.7M
Total Liabilities $141.4M $312.0M
YoY Change -54.68% 103.68%
SHAREHOLDERS EQUITY
Retained Earnings -$667.4M
YoY Change
Common Stock $700.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.14M -$60.90M
YoY Change
Total Liabilities & Shareholders Equity $172.3M $251.1M
YoY Change -31.4% 0.62%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$55.34M -$69.97M
YoY Change -20.91% 18.97%
Depreciation, Depletion And Amortization $800.0K $700.0K
YoY Change 14.29% 75.0%
Cash From Operating Activities -$55.60M -$27.40M
YoY Change 102.92% 31.73%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$300.0K
YoY Change 233.33% -70.0%
Acquisitions
YoY Change
Other Investing Activities $5.000M
YoY Change
Cash From Investing Activities $4.100M -$300.0K
YoY Change -1466.67% -70.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $72.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K 69.10M
YoY Change -100.29% -38.63%
NET CHANGE
Cash From Operating Activities -55.60M -27.40M
Cash From Investing Activities 4.100M -300.0K
Cash From Financing Activities -200.0K 69.10M
Net Change In Cash -51.70M 41.40M
YoY Change -224.88% -54.41%
FREE CASH FLOW
Cash From Operating Activities -$55.60M -$27.40M
Capital Expenditures -$1.000M -$300.0K
Free Cash Flow -$54.60M -$27.10M
YoY Change 101.48% 36.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
44980000
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2420000
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
75192000
CY2016Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
2184000
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.08
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.72
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51291787
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40698309
CY2017Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
0
CY2016Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
50000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2111000
CY2017Q2 us-gaap Liabilities
Liabilities
141394000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5550000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
669000
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
75687000
CY2017Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
25229000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
5000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
700244000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-673000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-667436000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
32140000
CY2017Q2 us-gaap Minority Interest
MinorityInterest
-1283000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30857000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
172251000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
308000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
35947000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-120000
CY2017Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
596000
CY2016Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
588000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
411000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1300000
us-gaap Share Based Compensation
ShareBasedCompensation
11466000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-46000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
464000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1859000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1141000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2577000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-19743000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2287000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3668000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-88000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7370000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1118000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4848000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6933000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
279000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-128851000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2652000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
59862000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15000000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2449000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
75000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25000000
chrs Proceeds From Issuance Common Stock Offering Net Of Underwriters Discounts And Commissions
ProceedsFromIssuanceCommonStockOfferingNetOfUnderwritersDiscountsAndCommissions
69472000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
739000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
398000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
171000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
345000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
364000
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-92000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-356000
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
118300000
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-176000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1395000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
14068000
us-gaap Sales Revenue Net
SalesRevenueNet
1556000
us-gaap Sales Revenue Net
SalesRevenueNet
26427000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22601000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16798000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8054000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6026000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
838000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
729000
CY2017Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
464000
CY2017Q2 chrs Accrued Clinical And Manufacturing Liabilities Current
AccruedClinicalAndManufacturingLiabilitiesCurrent
7639000
CY2016Q4 chrs Accrued Clinical And Manufacturing Liabilities Current
AccruedClinicalAndManufacturingLiabilitiesCurrent
16039000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6229000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6945000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3257000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1496000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15216160
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14596534
CY2017Q2 us-gaap Restructuring Charges
RestructuringCharges
3600000
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
2100000

Files In Submission

Name View Source Status
0001564590-17-016017-index-headers.html Edgar Link pending
0001564590-17-016017-index.html Edgar Link pending
0001564590-17-016017.txt Edgar Link pending
0001564590-17-016017-xbrl.zip Edgar Link pending
chrs-10q_20170630.htm Edgar Link pending
chrs-20170630.xml Edgar Link completed
chrs-20170630.xsd Edgar Link pending
chrs-20170630_cal.xml Edgar Link unprocessable
chrs-20170630_def.xml Edgar Link unprocessable
chrs-20170630_lab.xml Edgar Link unprocessable
chrs-20170630_pre.xml Edgar Link unprocessable
chrs-ex311_8.htm Edgar Link pending
chrs-ex312_7.htm Edgar Link pending
chrs-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending